Differential pricing of new pharmaceuticals in lower income European countries.

Abstract

Pharmaceutical companies adjust the pricing strategy of innovative medicines to the imperatives of their major markets. The ability of payers to influence the ex-factory price of new drugs depends on country population size and income per capita, among other factors. Differential pricing based on Ramsey principles is a 'second-best' solution to correct the… (More)
DOI: 10.1586/14737167.2013.847367

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.